CRISPR-Cas12a with an oAd Induces Precise and Cancer-Specific Genomic Reprogramming of EGFR and Efficient Tumor Regression-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

CRISPR-Cas12a with an oAd Induces Precise and Cancer-Specific Genomic Reprogramming of EGFR and Efficient Tumor Regression

Published:2020-10 Issue:10 Volume:28 Page:2286-2296
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Yoon A-Rum,Jung Bo-Kyeong,Choi Eunyoung,Chung Eugene,Hong JinWoo,Kim Jin-Soo,Koo Taeyoung,Yun Chae-Ok

Funder

Kyung Hee University

National Research Foundation of Korea

Korea Drug Development Fund

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference51 articles.

1. Cornerstones of CRISPR-Cas in drug discovery and therapy;Fellmann;Nat. Rev. Drug Discov.,2017

2. Applications of the CRISPR-Cas9 system in cancer biology;Sánchez-Rivera;Nat. Rev. Cancer,2015

3. CRISPR-Cas9 for in vivo gene therapy: promise and hurdles;Dai;Mol. Ther. Nucleic Acids,2016

4. Therapeutic applications of CRISPR RNA-guided genome editing;Koo;Brief. Funct. Genomics,2017

5. Selective disruption of an oncogenic mutant allele by CRISPR/Cas9 induces efficient tumor regression;Koo;Nucleic Acids Res.,2017

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CRISPR-mediated ablation of TP53 and EGFR mutations enhances gefitinib sensitivity and anti-tumor efficacy in lung cancer;Molecular Therapy;2024-07

2. Gene targeting in adult organs using in vivo cleavable donor plasmids for CRISPR-Cas9 and CRISPR-Cas12a;Scientific Reports;2024-03-31

3. Current progress in CRISPR–Cas systems for cancer;Progress in Molecular Biology and Translational Science;2024

4. Oncolytic Viruses in the Era of Omics, Computational Technologies, and Modeling: Thesis, Antithesis, and Synthesis;International Journal of Molecular Sciences;2023-12-12

5. Research progress on nucleic acid detection and genome editing of CRISPR/Cas12 system;Molecular Biology Reports;2023-01-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3